Background: Modern molecular-based approaches for the detection of M. tuberculosis in sputum samples promise quicker and more accurate detection of cases. However, processing sputum samples at central diagnostic facilities provides a diagnostic approach, but requires a safe and efficient system that is not affected by transport delays and ambient temperature to be feasible. We evaluated the technical properties of PrimeStore® -Molecular Transport Medium (PS-MTM) for its ability to inactivate mycobacteria, ensuring stability of DNA over time at ambient temperatures and to assess the compatibility of the transport medium with DNA extraction systems. Conclusions: Collecting and transporting sputum from TB suspects in PS-MTM offers safe transport at ambient temperature, DNA stability for extended periods without cooling and specimens directly suitable for molecular testing. This novel approach may support introduction and further scale-up of molecular diagnostics for TB in resource-limited settings.
INTRODUCTION
Current tuberculosis (TB) infection rates are estimated to be the highest in the history of the disease, where 22 middle-to-low income countries are burdened with 80% of active disease (Paulson, 2013 , WHO, 2010 . To improve diagnosis of TB, the World Health Organization (WHO) promotes the early introduction of rapid molecular testing globally (WHO, 2013) . In light of that, South Africa has replaced smear microscopy with the molecular Xpert MTB/RIF assay (Xpert, Cepheid, Sunnyvale, CA, USA) in its National algorithm. A similar scenario may not be possible in other countries due to relatively high associated cost and poor infrastructure.
This warrants exploration of alternative approaches to introduce molecular diagnostics in high-burden countries, for example by transporting sputum specimens to a centralized molecular diagnostic facility. In that regard, safe (inactivated for purpose of infection control) and efficient (preservation and stability of DNA) transportation of sputum specimens is of paramount importance. Several methods have been described for inactivation of viable Mycobacterium tuberculosis from cultures by either heat or a combination of heat and the use of chemicals (Djelouagji and Drancourt, 2006 , Doig et al., 2002 , Inoue et al., 2014 . However, the only relevant published data on the effect of reagents added directly to sputum on the viability of TB bacilli is the sample reagent buffer (SR) of the Xpert assay. The SR has demonstrated capability of producing an 8 log reduction, within 15 minutes, in M. tuberculosis viability in sputum spiked with this organism (Helb et al., 2010) . In M. tuberculosis-positive sputum specimens, with bacillary loads of less than 10 7 colony forming units/milliliter (CFU/ml), total inactivation was achieved within 15 minutes (Banada et al., 2010) . In practice, the SR buffer is only added to the sample when processed at the laboratory and not intended for specimen transport.
The effect of ambient transportation and subsequent delays to laboratory testing on sputum M. tuberculosis bacillary and DNA loads for molecular testing is not known, unlike the documented negative effects of delay on culture yield of sputum specimens (Banda et al., 2000 , Paramasivan et al., 1983 . However, studies on other pathogens in different clinical specimens have shown a negative effect on molecular testing when kept at ambient temperature for extended periods of time (Hasan et al., 2012 , Ingersoll et al., 2008 . In that context, the manufacturer of the Xpert assay recommends that sputum samples be kept for no longer than 3 days at ambient temperatures up to 35° C until processing (Banada, et al., 2010) . Delays in transport and testing could negatively affect the diagnostic yield when using sputum specimens.
A liquid transport medium, PrimeStore® -Molecular Transport Medium (PS-MTM); Longhorn
Vaccines & Diagnostics, San Antonio, TX, USA) is a commercial specimen collection and transport solution, specifically formulated for downstream molecular diagnostic testing. The proposed use of this chemically defined medium, composed of chaotrophic, chelating, reducing and defoaming agents, detergents and electrolytes to buffer to an optimal pH, is for inactivation and lysis of biological pathogens as well as stabilizing/preserving the released nucleic acids (DNA and RNA) for prolonged periods. PS-MTM has been reported to reduce viability of microorganisms almost completely (99.9%) using a standard panel of variety of viruses, bacteria and fungi, but not including M. tuberculosis . Furthermore, complete viral inactivation of enveloped viruses occurred within seconds after being placed in PS-MTM and viral RNA was preserved for up to 30 days at ambient temperature .
Expanding potential use of PS-MTM to TB diagnostics, a recent study of PS-MTM showed inactivation within 30 min of M. tuberculosis at a bacillary load of 10 6 CFU/ml (Daum et al., 2014) . Based on the relatively scant information on the use of PS-MTM for TB diagnosis and research, as indicated above, insight into its potential application in routine diagnostics of TB is warranted. In this study, we aim to determine further the performance and safety potential use of PS-MTM as a collection vehicle and transport preservation method of sputum specimens for molecular detection and characterization of M. tuberculosis.
MATERIALS AND METHODS

Design and steps of evaluation
The value of PS-MTM was determined in several steps: (a) potential for inactivation of M.
tuberculosis at high bacterial loads with both cultured bacilli as well as spiked sputum samples, 
Preparation of M. tuberculosis suspensions for laboratory evaluations
Standard M. tuberculosis suspensions were prepared by growing the M. tuberculosis H37Rv laboratory strain (ATCC 27294) as per routine protocol to the turbidity of a 0.5 McFarland standard; the equivalent concentration of x 8 CFU/ml (Bollela et al., 1999 , Global Laboratory Initiative, 2014 , Murray and Baron, 2007 . The optical turbidity was measured using the PhoenixSpec Nephelometer (BD Diagnostics, Franklin lakes, NJ, USA) against a standard curve. A series of ten-fold dilutions was prepared from the McFarland standard, producing concentrations ranging from 10 6 to 10 1 CFU/ml. Manual colony counts to confirm the dilution series plated on Middlebrook 7H11 agar medium were performed for the concentrations that could be enumerated (10 1 -10 3 CFU/ml).
Inactivation of M. tuberculosis in PS-MTM
The ability of PS-MTM to inactivate M. tuberculosis was assessed for purified culture isolates and spiked sputum samples. A 0.5 ml suspension of M. tuberculosis Rv strain x 10 8 cfu/ml) was inoculated into 1.5 ml of PS-MTM, briefly vortexed and sampled after ambient temperature incubation for 5, 10, 20, 40, 80 and 160 seconds. Sample aliquots of 0.2ml were directly plated on Middlebrook 7H11 agar and 0.5ml inoculated into liquid culture and processed using the Bactec Mycobacterial Growth Indicator Tubes MGIT) 96 ™ Becton Dickinson Diagnostics, Sparks, MD, USA) as previously described (Siddiqi and Rusch-Gerdes, 2006) . A positive control was included (suspension in saline without PS-MTM) and the experiment was performed in triplicate. Sputum samples not submitted for TB investigation were obtained from the routine diagnostic laboratory at the University of Pretoria and assessed for the presence of acid-fast bacilli (AFB) by smear microscopy, cultured by MGIT to confirm the absence of M.
tuberculosis followed by quality assessment using the Bartlett Scoring System (Winn Jr et al., 2005) . Good quality purulent sputum specimens (Bartlett test score of 2+) were included for use in the spiking matrix experiments. These sputa were split and spiked with M. tuberculosis
H37Rv strain with concentrations of 1.5 x10 6 and 1.5 x 10 8 CFU/ml followed by inoculation into PS-MTM (without decontamination or other pre-culture steps). A matrix assessment to determine effect of concentration was performed by adding to 1ml of spiked sputum 3, 2, 1, 0.5 and 0.2 ml of PS-MTM. Samples were incubated in triplicate at ambient temperature for 1, 5, 10, 30, 60 and 180 minutes, including two positive and negative controls, and analyzed using the MGIT 960 system. Effective inactivation at certain concentration and time point was defined as no growth in all samples after 42 days.
Evaluation of DNA stability in sputum inoculated in PS-MTM
Three sputum specimens, positive for M. tuberculosis on microscopy for AFB, with a smear microscopy grading of 3+ were included in this evaluation. The sputum specimens were split into two equal aliquots with one added to PS-MTM at 1:2, and one refrigerated, with sterile water added to the latter aliquots at the same ratio as PS-MTM. Nucleic acid extraction using
NucliSENS easyMAG was performed on all test samples at baseline and weekly intervals over a 4 week period. This time period would be sufficient for the primary diagnosis, extended delays due to logistic challenges in countries with poor infrastructure and if needed specimen availability for additional reflex molecular testing if required. Preservation of DNA was measured by real-time PCR on each of the extracts where an absence of significant decrease in cycle-threshold (CT) scores over tested time points indicates stability.
Compatibility with three DNA extraction systems
Ten-fold dilutions of the M. tuberculosis stock solutions were prepared to a range of 10 1 to10 6 CFU/ml and spiked into 20 remnant clinical culture-negative sputum samples (as described in 2.2 and 2.3). These sputum samples were inoculated into PS-MTM at a volume ratio of 1:2.
The final concentration of M. tuberculosis in the spiked sputum ranged from an estimated 3 to 250 000 CFU/ml. Aliquots of sputum in PS-MTM were prepared and processed using the following DNA extraction systems as per manufacturers' instructions: the QiaAMP DNA mini kit (Qiagen, Hilden, Germany), the MagNA Pure 96 System (Roche Diagnostics, Mannheim, Germany) using the DNA Bacterial/Viral small volume kit, the NucliSENS easyMAG (Biomerieux, Marcy I'Etoile, France) using the generic protocol. The all-in-one extraction and detection system, the Xpert MTB/Rif assay was performed as a control for routine detection; an aliquot of sputum sample was tested by Xpert before inoculating in PS-MTM, as instructed by the manufacturer (Fig. 1 ). An input volume of 200µl PS-MTM sample was used with 50µl output volume except in the case of MagNA Pure 96 (Roche, Germany) where the final volume was 100µl. Real-time PCR targeting the M. tuberculosis specific insertion sequence element 6110 (IS6110) was used on the LightCycler 480II platform (Roche Diagnostics, Mannheim, Germany) to detect M. tuberculosis from DNA extracts. 
Evaluation of using swabs to inoculate sputum into PS-MTM for molecular testing
Flocculated cotton swabs (Copan Diagnostics Inc., Brescia, Italy) were evaluated for capacity to inoculate sputum into PS-MTM for downstream molecular testing. This swab-for-inoculation procedure was further evaluated in fourteen sputum specimens that were culture positive for M.
tuberculosis and with a known smear microscopy grading for AFB. The volume captured on swab was determined by the difference in swab weight pre-and post-collection using a calibrated laboratory scale (Adam Equipment Co. Ltd, Milton Keynes, UK). As a control the remaining volume was pipetted into an equal volume of PS-MTM. After inoculation, PS-MTM tubes were kept overnight at ambient temperature followed by DNA extraction on the MagNA
Pure 96 System and real-time PCR by LightCycler 480II.
Evaluation of detecting M. tuberculosis in clinical samples stored in PS-MTM
A total of 297 sputum specimens sent for TB investigation were prospectively collected at the Tshwane Academic Division (University of Pretoria) of the National Health Laboratory Service, South Africa. Specimens were included irrespective of quality; however, a minimum volume of 2ml was required to prevent compromising the routine testing. From each specimen, an aliquot was transferred into PS-MTM using the swab procedure. Routine diagnostic testing of specimens was performed using fluorescent microscopy (Auramine-O), mycobacterial culture on the MGIT 960 system with confirmation of M. tuberculosis in positive cultures by the TBcID rapid antigen test (BD, Sparks, MD, USA). DNA was extracted from the specimens stored in PS-MTM using the MagNA Pure 96 System followed by real-time PCR for M. tuberculosis detection by LightCycler 480II.
RESULTS
Inactivation of M. tuberculosis in PS-MTM
In order to assess the inactivation ability of PS-MTM, the high concentration suspension (of the reference strain was inoculated in triplicate into PS-MTM, stored at ambient temperature and 02:01 3/3 3/3 3/3 3/3 3/3 3/3 3/3 05:01 3/3 3/3 3/3 3/3 3/3 3/3 3/3
Evaluation of DNA stability in PS-MTM
Three microscopy smear-positive samples were split into two aliquots and stored in either PS-MTM at ambient temperature or in a normal sputum container, without processing, at refrigeration temperature (4° C). PCR detection of M. tuberculosis DNA from these containers was done on weekly basis for a period of four weeks. There was no significant change in Ctvalue (<5%) over time observed for samples stored in PS-MTM or for those stored at 4° C in a normal sputum container (Tab. 2). Note. Ambient temperature in this setting is generally 25-30° C.
Compatibility with DNA extraction systems
The automated magnetic bead-based extraction systems (NucliSENS EasyMAG and MagNA Pure 96 System) had estimated lower limits of detection of 169 and 173 CFU/ml respectively producing the highest DNA yield from specimens stored in PS-MTM (Tab.3). The yield was higher than for the silica-based extraction system (QiaAMP) which detected all replicates up to the 25000 CFU/ml concentration, but missed an increasing proportion of replicates at subsequent (lower) concentrations (2,500-25,000 CFU/ml) that were not missed by the bead-based methods (Tab.3). A significant difference was seen between the MagNA Pure and positive control (Xpert system) in their ability to detect positives a various concentration, with MagNA Pure maintaining * all replicate testing performed on each system used the same spiked sputum samples and were processed by sampling into PS-MTM †The positive control was not prepared using PS-MTM its ability to detect positives at the lower CFU/ml concentration (Chi-square =15.23 ;p=0.009). None of the other systems produced significantly different results from the Xpert control.
Swab procedure for inoculation of sputum into PS-MTM tubes
Using clinical culture-positive specimens, the estimated median volume of sputum captured by the swabbing procedure was 50µl and ranged from 50 µl -250µl where samples with a higher *WHO smear microscopy scoring system: For 3 scanty samples, numbers 9, 7, 1 indicate AFB/100 FOV **Sputum was inoculated at 1:1 ratio in PrimeStore (equal volume)
¥ No statistically significant differences across all results (smear positive and negative) between swab and pipette inoculation (Paired T = 0.70, DF=13, p=0.50).
viscosity (purulent) retained a lower volume of sample compared to those less viscous (salivary) (Tab.4).M. tuberculosis DNA was detected by real-time PCR in all samples using the swabbing procedure and in all except one of the pipetted samples. Cycle threshold values were generally lower for pipetted specimens, but the swab to PS-MTM ratio was relatively higher for those samples (1:1). DNA concentrations after extraction ranged between 231 and 281 ng/µl (data not shown). These concentrations comprise DNA of M. tuberculosis as well as DNA from host cells and commensal organisms present in sputum samples.
Detection of M. tuberculosis in clinical samples stored in PS-MTM
Of the 297 specimens prospectively collected; 41 were excluded from routine diagnostics due to poor sputum quality in 8 (2.7%) or culture contamination in 33 (11.1%) of which M. tuberculosis was detected in 5. Thus, from the specimens analyzed (n=256), 26 (10.2%) were culture positive including 13 (5.1%) that were smear positive. Real-time PCR of sputum in PS-MTM was positive in all smear-positive specimens (13/13) and 7/13 (54%) of smear-negative culturepositive sputum specimens (Tab. 5). PCR was positive in another 8 specimens (3.1%) that were negative by both microscopy and culture. 
DISCUSSION
This laboratory evaluation demonstrates that PS-MTM rapidly inactivates M. tuberculosis in sputum specimens thereby rendering the specimen safe, compatible with various nucleic acid extraction systems and suitable for downstream molecular processing in a routine diagnostic setting. These observations are in line with two studies describing evaluation of this transport medium for molecular processing of sputum specimens for respiratory viruses , Schlaudecker et al., 2014 . Our observations are of importance as concentrations of viral DNA or RNA are generally higher than of M. tuberculosis DNA in sputum samples.
Inactivation of the organism was measured by the ability to grow in an internationally standardized culture medium; the current gold standard to viability testing (van Zyl-Smit et al., 2011) . Maximum bacillary load of M. tuberculosis in a clinical sputum specimen is approximately 10 6 organisms/ml (Rieder et al., 2007) ; therefore we performed most laboratory experiments at this concentration and a 100-fold higher. With regard to mycobacterial inactivation, M. tuberculosis in pure culture, grown to a concentration of 10 8 CFU/ml, was inactivated within 5 seconds of exposure to the PS-MTM transport medium. However, time to inactivation of M. tuberculosis was considerably longer in the proteinaceous matrix of sputum.
The sputum to PS-MTM ratio is important and should be at least 1:2 to achieve complete inactivation in a reasonable period of time (60 minutes; 30 minutes at 1:3 ratio) at M. tuberculosis concentration of 1.5 x 10 8 CFU/ml. The rapid inactivation is in line with findings from Daum et al. (2014) , which showed that PS-MTM is an effective medium to inactivate a pure culture of M. tuberculosis at ~10 6 CFU/ml at an exposure time of 30 minutes. This is a similar effect as achieved by the Xpert SR buffer where an 8 and 9 log reduction was demonstrated at 15 minutes and 2 hours respectively (Helb, et al., 2010) . A minimum time of 60 minutes from collection to specimen processing is likely to be routine and will provide a safe specimen for downstream testing, particularly in resource-constrained settings.
Stability of M. tuberculosis DNA in PS-MTM at ambient temperature was demonstrated for a period of 4 weeks. This period is more than sufficient to use PS-MTM in a diagnostic approach.
However, additional follow-up testing is warranted to determine the value of PS-MTM for longterm bio banking. A limitation of this evaluation was not directly comparing the effect on DNA stability in sputum at ambient temperature in comparison to the PS-MTM sample.
PS-MTM was compatible with the most commonly used DNA extraction systems and in most cases did not differ in their ability to detect positives. Thus it could be used in most laboratories, regardless of their set-up, and for a variety of downstream molecular applications. The two automated magnetic bead-based extraction systems (NucliSENS easyMAG and MagNA Pure system), ideal for routine services due to their robustness, performed best and demonstrated similar high performance, efficiency and reproducibility. The observed difference in performance between magnetic bead and silica extraction systems may be due to loss of DNA released by PS-MTM, particularly during processing prior to silica binding.
Evaluation of almost 300 clinical sputum specimens using PS-MTM as pre-step demonstrated good sensitivity and specificity compared to smear microscopy and liquid culture. Performance was in line with generally accepted characteristics of molecular testing for M. tuberculosis: 90-100% sensitivity in microscopy smear-positive sputum specimens and 55-75% among smearnegative cases (Armand et al., 2011 , Dinnes et al., 2007 , Miller et al., 2011 , Steingart et al., 2014 . There was no apparent effect of chemical composition of PS-MTM on detection of lower bacillary loads as diagnostic performance among smear-negative cases was adequate.We did not test amplification suppression, but think that the effect, if present, was minimal as we were able to successfully amplify M. tuberculosis at relatively low CFU/ml as well as detect smear negative TB cases in the clinical laboratory evaluation. This was achieved by transferring a very small quantity of the primary sputum specimen (0.2 ml) into PS-MTM. Although the volume captured on a swab is only an estimated fifth of the volume required for the Xpert assay, this small volume was sufficient to adequately detect M. tuberculosis at sensitivities similar to that of the Xpert assay.
The method of using swabs to inoculate sputum into PS-MTM provides an adequate yield for molecular processing. Moreover, it provides a practical approach that allows healthcare workers to directly inoculate sputum into PS-MTM for rapid inactivation and stabilization after the specimen is produced. Such an alternative method is warranted as pipetting sputum at healthcare facilities would not be feasible.
CONCLUSIONS
PS-MTM may have several applications in addition to the diagnosis of M. tuberculosis including: safe transport and preservation of specimen for molecular testing, its inactivating capability of pure cultures could allow the convenient ambient temperature transport of the organism for surveillance activities (i.e. molecular typing and sequencing) and ambient temperature molecular bio banking which could remove the current storage costs associated with the conventional method. Continuous improvements in molecular diagnostics require innovative methods for transporting specimens safely, efficiently and without compromising integrity that may influence diagnosis. With regard to M. tuberculosis detection, PS-MTM provides a promising tool for transport between clinical and centralized diagnostic facilities for molecular testing which could expand molecular diagnosis of tuberculosis in resource-poor settings.
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